Introducing LinkZill TruArray™ Std high-throughput oligonucleotide microarray chip

2024-12-12

We are excited to announce the launch of LinkZill’s first standardized product based on TFT-DNA synthesis technology —— TruArray™ Std high-throughput oligonucleotide microarray chip!

The TruArray™ series offers world-leading technical specifications, including superb coverage and uniformity, superior oligo length, and flexible throughput and oligo amounts. TruArray™ can be applied across various fields, including high-throughput sequence screening, in situ gene synthesis and protein expression, antibody and aptamer discovery, high-throughput genotyping, multiplex detection of pathogenic microorganisms, and in situ spatial omics technologies.

Currently, the TruArray™ Std 4K Microarray with oligonucleotide lengths of up to 150 nt is now taking orders! Let’s unlock new possibilities in research and innovation with TruArray™.

If you have any questions or need further information, please feel free to contact us: info@linkzill.com

 

Dr. Kang Kang

Partner & CBio

Dr. Kang received his Ph.D. in Bioinformatics and Systems Biology from the University of Hong Kong in 2018, then became a scientific co-worker of the Leibniz Association (Leibniz-HKI) and a visiting scientist at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) at the Technical University of Denmark. He was a scientist at BGI-Shenzhen and co-founded the synthetic biology research group. He was a senior bioinformatics engineer and brand advisor at WeGene. In 2021, Kang joined Biosysen Limited as a co-founder and served as Chief Informatics Scientist. He is also an advisor and author of the biotech media "Regenesis". He has been dedicated to the R&D and industrialization of OMICs technologies, high-throughput technologies, and synthetic biology for over 10 years. He joined LinkZill in March 2023, responsible for semiconductor life science tools and product planning.